Our client is a diagnostics start-up (founded ~2020) that’s now hitting a genuine inflection point:
- Proven science + strong IP in biomarker-driven infection/inflammation detection
- Existing commercial credibility (incl. prior partnership with major players)
- Series B closing + bridge funding secured
- And a very clear plan to enter and scale in the US market
They’ve built the foundation. Now they need someone to own the clinical engine.
The product:
- Handheld, point-of-care diagnostic device (think bedside use)
- Rapid blood-based testing with quantified biomarker outputs
- Designed to support real-time clinical decision-making
It’s already been through:
- Pilot study
- Academic collaboration
- Early adult data
Next step = scale and validate properly.
What’s needed:
A Clinical Research & Medical Affairs leader who can:
- Design and own new US-based clinical studies
- Build protocols from scratch and challenge CROs / research partners
- Structure studies to generate regulatory-grade outcomes
- Lead the pathway toward 510(k) or Breakthrough designation
- Engage directly with clinicians, investigators, and early adopters
- Represent the company at conferences + in publications
The profile:
- Clinical leader (~Director level)
- Strong Diagnostics / IVD background
- Someone who can think critically, not just execute
- Comfortable wearing multiple hats in a 10-person, high-growth team
- Able to bridge science, clinical, and commercial conversations
Culturally:
- Hands-on
- Curious
- Willing to challenge thinking
- Happy being in the room with leadership
(Cambridge, London, Oxford triangle base preferred, with occasional on-site work)
Why it stands out:
- Series B + active VC discussions
- US market entry from the ground up
- Real ownership of clinical strategy
- Publications + visibility
- Equity upside tied to a clear exit path
This is one of those roles where you’re not just advancing your career, you’re helping define and develop the company towards success.
If that sounds exciting, reach out today.